Nanopartículas RSS
Novavax, the recombinant nanoparticle Covid-19 vaccine.
Novavax is a new recombinant nanoparticle vaccine of coronavirus 2 (SARS-CoV-2) with an adjuvant, based on saponins extracted from the bark of Quillaja saponaria Molina that improves immune responses and allows for a reduction in the vaccine dose.